Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol)
- PMID: 11342147
- DOI: 10.1016/s0005-2736(00)00335-7
Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol)
Abstract
Incorporation of 5 mol% poly(ethylene glycol)-conjugated lipids (PEG-lipids) has been shown to extend the circulation longevity of neutral liposomes due to steric repulsion of PEG at the membrane surface. The effects of PEG-lipids on protein interactions with biologically reactive membranes were examined using phosphatidylserine (PS) containing liposomes as the model. Incorporating 15 mol% 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE)-PEG 2000 into PS liposomes resulted in circulation lifetimes comparable to that obtained with neutral liposomes containing 5 mol% DSPE-PEG 2000. These results suggested that 15 mol% DSPE-PEG 2000 may be effective in protecting PS liposomes from the high affinity, PS-mediated binding of plasma proteins. This was determined by monitoring the effects of PEG-lipids on calcium-mediated blood coagulation protein interactions with PS liposomes. Prothrombin binding and procoagulant activity of PS liposomes could be inhibited >80% when 15 mol% DSPE-PEG 2000 was used. These results are consistent with PS on membrane surfaces forming transient nucleation sites for protein binding that may result in lateral exclusion of PEG-lipids incorporated at <10 mol%. These nucleation sites may be inaccessible when PEG-lipids are present at elevated levels where they adopt a highly compressed brush conformation. This suggests that liposomes with reactive groups and PEG-lipids may be appropriately designed to impart selectivity to protein interactions with membrane surfaces.
Similar articles
-
Effects of phosphatidylserine on membrane incorporation and surface protection properties of exchangeable poly(ethylene glycol)-conjugated lipids.Biochim Biophys Acta. 2002 Feb 18;1560(1-2):37-50. doi: 10.1016/s0005-2736(01)00455-2. Biochim Biophys Acta. 2002. PMID: 11958774
-
Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.Biochim Biophys Acta. 2007 Jun;1768(6):1367-77. doi: 10.1016/j.bbamem.2006.12.013. Epub 2007 Jan 3. Biochim Biophys Acta. 2007. PMID: 17400180
-
Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes.Biochim Biophys Acta. 2001 Aug 6;1513(2):193-206. doi: 10.1016/s0005-2736(01)00351-0. Biochim Biophys Acta. 2001. PMID: 11470091
-
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17. Eur J Pharm Biopharm. 2013. PMID: 23872180 Review.
-
DSPE-PEG: a distinctive component in drug delivery system.Curr Pharm Des. 2015;21(12):1598-605. doi: 10.2174/1381612821666150115144003. Curr Pharm Des. 2015. PMID: 25594410 Review.
Cited by
-
Passive transfer of polyethylene glycol to liposomal-recombinant human FVIII enhances its efficacy in a murine model for hemophilia A.J Pharm Sci. 2008 Sep;97(9):3753-64. doi: 10.1002/jps.21266. J Pharm Sci. 2008. PMID: 18300296 Free PMC article.
-
Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.J Pharm Sci. 2011 Jan;100(1):38-52. doi: 10.1002/jps.22243. J Pharm Sci. 2011. PMID: 20575003 Free PMC article. Review.
-
Molecular Simulations of PEGylated Biomolecules, Liposomes, and Nanoparticles for Drug Delivery Applications.Pharmaceutics. 2020 Jun 10;12(6):533. doi: 10.3390/pharmaceutics12060533. Pharmaceutics. 2020. PMID: 32531886 Free PMC article. Review.
-
Baicalein Long-Circulating Liposomes Improve Histological and Functional Outcomes After Traumatic Brain Injury.Adv Pharmacol Pharm Sci. 2024 Nov 22;2024:2869332. doi: 10.1155/adpp/2869332. eCollection 2024. Adv Pharmacol Pharm Sci. 2024. PMID: 39624070 Free PMC article.
-
Effect of pegylated phosphatidylserine-containing liposomes in experimental chronic arthritis.BMC Pharmacol Toxicol. 2015 Sep 22;16:24. doi: 10.1186/s40360-015-0022-0. BMC Pharmacol Toxicol. 2015. PMID: 26392267 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources